Description: Background: Hypertension is the most common modifiable risk factor for cardiovascular disease and mortality, being prevalent in approximately one in four Canadian adults. Historically, Canada has been among the world’s leading nations in hypertension treatment and control rates. However, recent years have raised concern with declining trends in hypertension… Read More
Description: Depression is most often diagnosed, managed, and treated in primary care. The Canadian Task Force on Preventive Healthcare (CTFPHC) has released or will soon be releasing guidelines for family physicians on screening for depression among children & youth (2025), individuals during the pre- and postpartum period (PPP) (2022), and… Read More
Description : Le flux de la recherche clinique en cardiologie s’écoulant à un rythme très rapide, il faut constamment examiner les progrès réalisés dans les soins fondés sur des données probantes en lien avec les maladies cardiovasculaires. Cette séance mettra l’accent sur les principales nouveautés en matière de prévention et… Read More
Description: The stream of clinical research in cardiology flows at a very rapid pace, requiring a continuous look at advancements in evidence-based care related to cardiovascular disease. This session will highlight key updates in the prevention and treatment of cardiovascular diseases that can be integrated into everyday primary care practice. Read More
Description: Are you concerned about complications like retinopathy, nephropathy, heart attack, stroke, neuropathy, or even mortality in your patients with diabetes? With conflicting messages from Google searches, clinical guidelines, and research publications, it’s no wonder the risks seem unclear. Numbers vary widely—from rare (<1%) to alarmingly common (>50%)—and sometimes, even… Read More
